Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Melanoma 9Skin Neoplasms 2Neoplasms 2Uveal Melanoma 1Triple Negative Breast Neoplasms 1The Initial Aim of This Project is to Perform in Vitro Validation of Neoepitope Candidates Selected From Available Mutanome Data 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Healthy Volunteer 1Healthy Adults 1Glioblastoma 1Eye Neoplasms 1Esophageal Neoplasms 1Diabetes Mellitus, Insulin-Dependent, 12 1Carcinoma 1Brain Neoplasms 1Biliary Tract Neoplasms 1

Interventions

poly ICLC 1keyhole-limpet hemocyanin 1Photosensitizing Agents 1Peptides 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Healthy Volunteer × Peptides × Clear all
NCT02947854 2019-08-28

Study to Assess Safety, Tolerability and Immune Response of Fimaporfin-induced Photochemical Internalisation of Antigen/Adjuvant

PCI Biotech AS

Phase 1 Completed
96 enrolled

Healthy Volunteer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡